Elicio signals delay in mid-stage cancer vaccine study; shares slump

ReutersMar 31, 2025 5:25 PM

Biotech firm Elicio Therapeutics' ELTX.O shares fall 14% to an over 2-month low of $6.71

ELTX now expects mid-stage study data of its lead experimental vaccine, ELI-002, in Q3 2025 vs. previous expectation of H1 2025

Co is testing vaccine against certain types of solid tumors that are caused by mutations in the KRAS gene, which are common in pancreatic, colorectal, and non-small cell lung cancers

ELTX's net loss also widens in 2024 compared with 2023

As of last close, ELTX has risen 2.5% in the past 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

TradingKey - During the US market opening session on May 7, Tesla (TSLA.US) shares extended their rebound momentum, rising more than 2% at one point to open at $406, returning above the $400 level. On May 5 and 6, the stock touched the $400 mark intraday but closed below that threshold on both days.

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

With a sold-out HBM pipeline, leadership in G9 NAND technology, and a valuation that has yet to fully account for its 2030 trillion-dollar potential, Micron remains a cornerstone "buy" for any long-term tech portfolio.

Gold Price Forecast: U.S.-Iran Tensions Ease, Nonfarm Payrolls Looming, What’s Next for Gold?

TradingKey - After retesting the $4,500 level this Monday, gold prices (XAUUSD) staged a strong recovery of over $200 across Tuesday and Wednesday, breaking above the $4,700 mark. As of press time today (May 7), the gold price maintains its upward momentum, trading at $4,748.77. The $4,800 threshold

WTI and Brent Futures Both Fall Below $100 Mark, Have Oil Prices and Energy Sector Peaked?

TradingKey - WTI crude oil futures settled at $96.21 per barrel on May 6, plummeting 6.3%. This marked the first close below the $100 level in six days and the largest single-day decline since March 17. Brent crude oil futures fell over 7.73% on the same day, intraday breaking below the $100 mark for the first time since April 22.

IONQ First-Quarter Earnings Beat Expectations, Shares Fall After Hours; Is IONQ Still Worth Investing?

TradingKey - IONQ’s latest earnings beat expectations, but shares fell after-hours as the market had previously overextended performance expectations; the medium-to-long-term outlook remains bullish.

Featured Tools